Topic

Derek Choy is co-founder & COO of Aktana.

Articles

Digital engagement is becoming the new normal, but it can inhibit the individual connection that is foundational to building long-term customer relationships. How can reps, brand teams, and medical science liaisons strike the right balance of personal and non-personal engagement? The next generation of AI has an answer, writes Derek Choy.




AI 2.0: The Humanizing of Machine Learning Technology

Pharma marketers can use their "voice" to increase prominence in advertising.

What Do Pharma Marketers Need to Know About Voice?

Iperion Life Sciences Consultancy in Rockville, Maryland in the US. She is a specialist in project management, IDMP and ICSR training and implementation. Iperion, which operates globally, is paving the way to digital healthcare through its proactive support for standardization and by ensuring the right technology, systems and processes are in place to facilitate process innovation.

Lise Stevens explores what difference the ISO IDMP (Identification of Medicinal Products) data standards would have made in a COVID-19 context — in applications ranging from pharmacovigilance adverse event reporting and electronic prescribing to falsified medicines control.

IDMP in a COVID Context

Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at jupton@mjhlifesciences.com

The Medical Affairs Digital Strategy Council's Mary Alice Dwyer and Indegene's Sameer Lal talk to Pharm Exec about how digital solutions can help the Medical Affairs function take a leadership role  in ensuring fast, efficient, and meaningful responses to all stakeholders at a time of intense pressure.

Implementing a Customer-Centric Mindset in Medical Affairs

Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at 

Report sets out self-assessment measures for low- and middle-income countries in their adoption of new health technologies.

The COVID Boost to AI in Global Health

Technology has potential to change how physicians work with asthma patients

New Launches Complete Teva’s Digital Inhaler Portfolio

A look at how UCB is utilizing dynamic targeting via AI to improve overall patient experience.

How AI Is Carving UCB’s Path to Better Patient Insights  

Pharma companies are struggling to maintain a high level of cybersecurity amidst the pandemic.

Examining Data Breaches in Pharma Companies During COVID-19

As we wait for a COVID-19 vaccine, pharma is looking to blockchain technology to prepare for the major supply-chain obstacles to come.

Vaccine Supply: Trusting in Blockchain

Peter Kohut is Director of Drug Safety at Arriello and an experienced EU QPPV. He began his career in biochemical research, before entering the pharmaceutical industry where he has worked in both clinical trials and post-marketing safety roles. Arriello is a global provider of innovative, high-impact market access, regulatory affairs & pharmacovigilance solutions and services for pharma and biotech firms primarily in Europe and North America.

Peter Kohut analyses the findings of a survey on how life sciences companies are capitalizing on opportunities to transform workload and data quality management using the latest smart technology.

Technology